ORAMED PHARMACEUTICALS INC. (37) | Business Operations (11)

Browse by Subcategory

Indemnification Agreements (6)
Services Agreements (5)

Recent Contracts

Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on May 12, 2022)
Clinical Research Organization Services Agreement dated September 16, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC (Filed With SEC on September 18, 2020)
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 24, 2021)
Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of its directors and officers (Filed With SEC on July 14, 2021)
Clinical Research Organization Services Agreement dated September 2, 2020 and effective as of January 15, 2020, between Oramed Ltd. and Integrium, LLC (Filed With SEC on September 9, 2020)
Amendment to the Service Agreement, dated January 10, 2020, between KNRY Ltd. and Oramed Ltd (Filed With SEC on April 6, 2020)
Representative Form of Indemnification Agreement between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on January 9, 2020)
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on November 27, 2019)
Amendment #2 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC (Filed With SEC on July 10, 2019)
Representative Form of Indemnification Agreements between Oramed Pharmaceuticals Inc. and each of our directors and officers (Filed With SEC on July 10, 2019)
Amendment #1 to Clinical Research Organization Services Agreement Protocol # ORA-D-015 between Oramed, Inc. and Integrium, LLC (Filed With SEC on July 10, 2019)